Skip to content
AwardedSpainGoods€12,533,562

Acuerdo Marco del Suministro de Medicamentos de USO HUMANO DE EPOETÍNAS PARA LA INDICACIÓN DEL TRATAMIENTO DE A ANEMIA SINTOMÁTICA ASOCIADA A LA INSUFICIENCIA RENAL

Published
Published 17 February 2025
Deadline
Closed 24 March 2025

Overview

Resolución del Consorci de Salut i d'Atenció Social de Catalunya de la Adjudicación del Acuerdo Marco del Suministro de Medicamentos de USO HUMANO DE EPOETÍNAS PARA LA INDICACIÓN DEL TRATAMIENTO DE A ANEMIA SINTOMÁTICA ASOCIADA A LA INSUFICIENCIA RENAL

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€12,533,562
Procedure
Open
Published
17 February 2025
Deadline
Closed
Classification (CPV)
Various medicinal products

Award outcome

Award date
30 May 2025
Contract period
30 May 2025 → 25 May 2026
Winners
  • AMGEN SA
  • PFIZER, SLU
  • ROCHE FARMA, SAU
  • SANDOZ FARMACÉUTICA S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    2 June 2025

  2. Contract Notice

    17 February 2025

Contracting authority

  • Consorci de Salut i d'Atenció Social de Catalunya

    Procuring entity

    Barcelona, Spain

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Acuerdo Marco del Suministro de Medicamentos de USO HUMANO DE EPOETÍNAS PARA LA INDICACIÓN DEL TRATAMIENTO DE A ANEMIA SINTOMÁTICA ASOCIADA A LA INSUFICIENCIA RENAL — won by AMGEN SA +3 — Skim